John Smeraglia
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Oncology top 10%
- Immunology top 10%
- Cancer Research
- Co-authors
- Carlo L. BelloCharles M. BaumPhilip TimmermanSamuel E. DePrimoLaurie ShermanBrian I. RiniRobert J. MotzerDominic G. Spinella
- Topics
- Biosimilars and Bioanalytical Methods (15 papers)Protein purification and stability (4 papers)Cell Image Analysis Techniques (4 papers)
- Cited by
- GastroenterologyImmunologyOncology
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
John Smeraglia
28 papers receiving 857 citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 348
- Pulmonary and Respiratory Medicine 292
- Oncology 270
- Immunology 224
- Cancer Research 121
Countries citing papers authored by John Smeraglia
This map shows the geographic impact of John Smeraglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Smeraglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Smeraglia more than expected).
Fields of papers citing papers by John Smeraglia
This network shows the impact of papers produced by John Smeraglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Smeraglia. The network helps show where John Smeraglia may publish in the future.
Co-authorship network of co-authors of John Smeraglia
This figure shows the co-authorship network connecting the top 25 collaborators of John Smeraglia. A scholar is included among the top collaborators of John Smeraglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Smeraglia. John Smeraglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 12 | |
| 5 | 33 | |
| 6 | 5 | |
| 7 | 8 | |
| 8 | 30 | |
| 9 | 3 | |
| 10 | 143 | |
| 11 | 5 | |
| 12 | 2 | |
| 13 | 31 | |
| 14 | A phase I mass-balance study to evaluate the metabolism and excretion of [14C]-sunitinib (SU11248) in healthy male subjects | 6 |
| 15 | 255 | |
| 16 | 4 | |
| 17 | 114 | |
| 18 | 24 | |
| 19 | 38 | |
| 20 | 67 |
About John Smeraglia
John Smeraglia is a scholar working on Immunology, Biophysics and General Dentistry, having authored 28 papers that have together received 885 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (15 papers), Protein purification and stability (4 papers) and Cell Image Analysis Techniques (4 papers). The work is most often cited by research in Gastroenterology (61 citations), Immunology (224 citations) and Oncology (270 citations). John Smeraglia has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Carlo L. Bello, Charles M. Baum, Philip Timmerman, Samuel E. DePrimo, Laurie Sherman, Brian I. Rini, Robert J. Motzer, Dominic G. Spinella, M. Dror Michaelson and Steve White. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.